The trillion-dollar club has become crowded with mostly tech names riding the AI boom. Eli Lilly might soon join them for a far different reason: the weight-loss bonanza.
ELI Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
As competitive as the obesity drug market has become, Novo Nordisk's decision to slash the prices of its GLP-1 agonist drugs ...
Shares of Lilly rose as much as 1.7% on Friday, pushing its market value to about $1 trillion, according to data compiled by ...
21hon MSN
2 Major Stocks Want to Dominate the GLP-1 Market. Which One Looks Like the Leader Heading Into 2026?
2 Major Stocks Want to Dominate the GLP-1 Market. Which One Looks Like the Leader Heading Into 2026? Eli Lilly is currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback